Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
1,109
Views
20
CrossRef citations to date
0
Altmetric
Clinical Study

Serum NGAL and FGF23 may have certain value in early diagnosis of CIN

Huihui LiDepartment of Nephropathy, Xiangya Hospital Central-South University, Changsha, Hunan410008, China; View further author information
,
Zaixin YuDepartment of Cardiology, Xiangya Hospital Central-South University, Changsha, Hunan410008, ChinaView further author information
,
Lu GanDepartment of Nephropathy, Xiangya Hospital Central-South University, Changsha, Hunan410008, China; View further author information
,
Ling PengDepartment of Nephropathy, Xiangya Hospital Central-South University, Changsha, Hunan410008, China; View further author information
&
Qiaoling ZhouDepartment of Nephropathy, Xiangya Hospital Central-South University, Changsha, Hunan410008, China; Correspondence[email protected]
View further author information
Pages 547-553 | Received 30 Nov 2017, Accepted 07 Jun 2018, Published online: 03 Oct 2018

References

  • Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8:1482–1493.
  • Mccullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419–1428.
  • Shum HP, Kong HH, Chan KC, et al. Septic acute kidney injury in critically ill patients - a single-center study on its incidence, clinical characteristics, and outcome predictors. Ren Fail. 2016;38:706–716.
  • Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med. 2010;4:265–280.
  • Devarajan P, Mishra J, Supavekin S, et al. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab. 2003;80:365–376.
  • Quintavalle C, Anselmi CV, De Micco F, et al. Neutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injury. Circ Cardiovasc Interv. 2015;8:e002673.
  • Rocha PN, Macedo MN, Kobayashi CD, et al. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury. Antimicrob Agents Chemother. 2015;59:6913–6921.
  • Komaba H. New Developments in CKD-MBD. Development and progression of CKD-MBD in predialysis period when and how? Clin Calcium 2014;24:1771–1778.
  • Larsson T, Nisbeth ULF, Ljunggren Ö, et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 2003;64:2272–2279.
  • Leaf DE, Wolf M, Stern L. Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury. Nephrol Dial Transplant. 2010;25:1335–1337.
  • Zhang M, Hsu R, Hsu CY, et al. FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study. Ann Intensive Care. 2011;1:21.
  • Christov M, Waikar SS, Pereira RC, et al. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int. 2013;84:776–785.
  • Leaf DE, Wolf M, Waikar SS, et al. FGF-23 levels in patients with AKI and risk of adverse outcomes. Clin J Am Soc Nephrol. 2012;7:1217–1223.
  • European Society of Urogenital Radiology. Non-renal adverse reactions. ESUR. Available from http://www.esur.org/guidelines/ (cited 2017 February 19).
  • Solomon R. Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Clin J Am Soc of Nephrol. 2008;3:1242–1243.
  • Rudnick MR, Goldfarb S, Tumlin J. Contrast-induced nephropathy: is the picture any clearer?. Clin J Am Soc Nephrol. 2008;3:261–262.
  • Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264.
  • Stacul F, Van Der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–2541.
  • Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin(NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54:1012–1024.
  • Wang K, Duan CY, Wu J, et al. Predictive Value of Neutrophil Gelatinase-Associated Lipocalin for Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-analysis. Can J Cardiol. 2016;32:1033.e19–1029.
  • Zang XJ, An SX, Feng Z, et al. In vivo mechanism study of NGAL in rat renal ischemia-reperfusion injury. Genet Mol Res. 2014;13:8740–8748.
  • An S, Zang X, Yuan W, et al. Neutrophil gelatinase-associated lipocalin (NGAL) may play a protective role against rats ischemia/reperfusion renal injury via inhibiting tubular epithelial cell apoptosis. Ren Fail. 2013;35:143–149.
  • Ezumba I, Quarles LD, Kovesdy CP. FGF23 and the heart. G Ital Nefrol. 2014;31:gin/31.6.12.
  • Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121:4393–4408.
  • Speer T, Groesdonk HV, Zapf B, et al. A single preoperative FGF23 measurement is a strong predictor of outcome in patients undergoing elective cardiac surgery: a prospective observational study. Crit Care. 2015;19:190.
  • Ali FN, Hassinger A, Price H, et al. Preoperative plasma FGF23 levels predict acute kidney injury in children: results of a pilot study. Pediatr Nephrol. 2013;28:959–962.
  • Duan N, Zhao J, Li Z, et al. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: A meta-analysis of randomized controlled trials. Med Sci Monit. 2015;21:292–297.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.